Randomized, phase III, double-blind, vehicle-controlled clinical trial to evaluate the safety and efficacy of 12 weeks of twice-daily azelaic acid foam, 15% in papulopustular rosacea

被引：0

作者：

Draelos, Zoe D. ^{[1
]}

Elewski, Boni E. ^{[2
]}

Harper, Julie C. ^{[3
]}

Sand, Meike ^{[4
]}

Staedtler, Gerald ^{[4
]}

Nkulikiyinka, Richard ^{[4
]}

Shakery, Kaweh ^{[4
]}

机构：

[1] Dermatol Consulting Serv, High Point, NC USA

[2] Univ Alabama Birmingham, Birmingham, AL USA

[3] Dermatol & Skin Care Ctr Birmingham PC, Birmingham, AL USA

[4] Bayer Healthcare, Global Dev, Berlin, Germany

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2015年 / 72卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

850

引用

页码：AB59 / AB59

页数：1

共 50 条

[1] A Phase 3 Randomized, Double-blind, Vehicle-Controlled Trial of Azelaic Acid Foam 15% in the Treatment of Papulopustular Rosacea
Draelos, Zoe Diana
Elewski, Boni E.
Harper, Julie C.
Sand, Meike
Staedtler, Gerald
Nkulikiyinka, Richard
Shakery, Kaweh
CUTIS, 2015, 96 (01): : 54 - 61
[2] Azelaic Acid Foam 15% in the Treatment of Papulopustular Rosacea: A Randomized, Double-blind, Vehicle-Controlled Study
Draelos, Zoe Diana
Elewski, Boni
Staedtler, Gerald
Havlickova, Blanka
CUTIS, 2013, 92 (06): : 306 - 317
[3] Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: Results from two vehicle-controlled, randomized phase III studies
Thiboutot, D
Thieroff-Ekerdt, R
Graupe, K
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003, 48 (06) : 836 - 845
[4] Pimecrolimus cream 1% for papulopustular rosacea: a randomized vehicle-controlled double-blind trial
Weissenbacher, S.
Merkl, J.
Hildebrandt, B.
Wollenberg, A.
Braeutigam, M.
Ring, J.
Hofmann, H.
BRITISH JOURNAL OF DERMATOLOGY, 2007, 156 (04) : 728 - 732
[5] Investigator-Reported Efficacy of Azelaic Acid Foam 15% in Patients With Papulopustular Rosacea: Secondary Efficacy Outcomes From a Randomized, Controlled, Double-blind, Phase 3 Trial
Solomon, James A.
Tyring, Stephen
Staedtler, Gerald
Sand, Meike
Nkulikiyinka, Richard
Shakery, Kaweh
CUTIS, 2016, 98 (03): : 187 - 194
[6] Patient-Reported Outcomes of Azelaic Acid Foam 15% for Patients With Papulopustular Rosacea: Secondary Efficacy Results From a Randomized, Controlled, Double-blind, Phase 3 Trial
Tyring, Stephen
Solomon, James A.
Staedtler, Gerald
Lott, Jason P.
Nkulikiyinka, Richard
Shakery, Kaweh
CUTIS, 2016, 98 (04): : 269 - 275
[7] Efficacy and Safety of Ivermectin 1% Cream in Treatment of Papulopustular Rosacea: Results of Two Randomized, Double-Blind, Vehicle-Controlled Pivotal Studies
Gold, Linda Stein
Kircik, Leon
Fowler, Joseph
Tan, Jerry
Draelos, Zoe
Fleischer, Alan
Appell, Melanie
Steinhoff, Martin
Lynde, Charles
Liu, Hong
Jacovella, Jean
JOURNAL OF DRUGS IN DERMATOLOGY, 2014, 13 (03) : 316 - 323
[8] A randomized, double-blind, vehicle-controlled study to evaluate the safety and efficacy of topical diclofenac 3% gel for the treatment of rosacea
Weiss, S
Jangua, R
Jacobson, C
Kimball, A
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P26 - P26
[9] Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial
Guenther, L
Cambazard, F
Van de Kerkhof, PCM
Snellman, E
Kragballe, K
Chu, AC
Tegner, E
Garcia-Diez, A
Springborg, J
BRITISH JOURNAL OF DERMATOLOGY, 2002, 147 (02) : 316 - 323
[10] Consistent efficacy and safety in four double-blind vehicle-controlled studies of ivermectin 1% cream in the treatment of moderate to severe papulopustular rosacea
Gold, Linda Stein
York, J. P.
Jacovella, Jean
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB87 - AB87

← 1 2 3 4 5 →